" /> Autologous CRISPR-edited Anti-CD19 CAR T Cells XYF19 - CISMeF





Preferred Label : Autologous CRISPR-edited Anti-CD19 CAR T Cells XYF19;

NCIt synonyms : CRISPR (HPK1)-edited CD19-specific CAR-T Cells XYF19; CAR-T Cells XYF19; Autologous CRISPR-edited CD19-specific CAR-T Cells XYF19;

NCIt definition : A preparation of autologous T-lymphocytes transduced with a lentiviral vector encoding a chimeric antigen receptor (CAR) specific for the tumor-associated antigen (TAA) CD19, and electroporated with clustered regularly interspaced short palindromic repeats (CRISPR) guide RNA to disrupt expression of endogenous hematopoietic progenitor kinase 1 (HPK1), with potential immunostimulating and antineoplastic activities. Upon introduction into the patient, the autologous CRISPR-edited anti-CD19 CAR T-cells XYF19 recognize and bind to CD19-overexpressing tumor cells. This may result in a specific cytotoxic T-lymphocyte (CTL)-mediated killing of CD19-positive tumor cells. Disrupting the expression of HPK1 may enhance immune response and autoimmunity. CD19 antigen is a B-cell specific cell surface antigen expressed in all B-cell lineage malignancies. HPK1 is a Ste20-like serine/threonine kinase that suppresses immune responses and autoimmunity.;

Molecule name : XYF-19; XYF 19;

NCI Metathesaurus CUI : CL1383074;

Details


Keyword's position in hierarchy(ies) : arborescence

You can consult :


Nous contacter.
12/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.